Earnings call transcript: OFX Group Q2 2026 highlights strategic challenges

OFX reported FY2026 net operating income of AUD 196.6 million, down 8.5% year over year, while underlying EBITDA fell 69.3% to AUD 25.2 million and the stock dropped 4.5% to AUD 0.53. Revenue declined across all major regions, including a 10.5% fall in North America, as macro headwinds and client migrations weighed on trading. Management remains constructive on FY2027, citing OFX 2.0 rollout progress, growing non-FX revenue, and a target of returning to positive operating leverage over the medium term.

Analysis

The earnings miss is less about a one-off demand dip and more about a classic platform-transition cash trap: OFX is absorbing migration friction before the revenue mix shift can compound. The key second-order effect is that the new platform should improve retention and cross-sell only after the client base becomes sufficiently “sticky,” so the near-term revenue math is still dominated by lower-activity cohorts and the unwind of legacy products. That means the market is likely underestimating how long reported growth can stay muted even if product adoption metrics improve.

What matters most from here is not top-line stabilization but whether multi-product penetration keeps rising fast enough to offset weaker FX volumes. If adoption continues to expand from the current low base, the company’s economics can re-rate sharply because incremental non-FX revenue has much better operating leverage than the legacy payment-only model. But if client acquisition remains reliant on macro normalization, the stock stays hostage to SMEs’ willingness to hedge and transact, which is a lagging indicator and can disappoint for several quarters.

The contrarian read is that the strategic review creates embedded optionality the market is not pricing correctly. Even if no corporate action emerges, management now has a cleaner proof point for a higher-quality asset than the current multiple implies, and any credible monetization pathway could re-anchor valuation quickly. The biggest risk is that a “good enough” strategic review outcome plus weak FY27 guidance leaves holders with a cheap but still deteriorating asset — a value trap until operating leverage turns visible.

For competitors, banks remain the hidden loser if OFX’s workflow expansion works: once clients move from single-purpose FX into embedded AP, cards, and wallet balances, switching costs rise materially. That can pressure smaller niche FX providers more than the headline numbers suggest, because OFX is effectively moving up the value chain from price-taker to workflow owner.

Key Decisions for Investors

• Long OFX-style turnaround exposure via a small starter long in undervalued fintechs with platform migration upside; use 3-6 month horizon and add only on evidence of sustained multi-product penetration, since the first rerating catalyst is likely operational rather than macro.
• Pair trade: long a scaled workflow-fintech beneficiary versus short legacy FX/payments names with low non-FX mix; thesis is that operating leverage accrues to platforms with recurring revenue, while single-product models remain volume-cyclical over the next 2-4 quarters.
• If accessible, buy 6-12 month out-of-the-money calls on the company as a strategic-review asymmetry trade; risk is limited premium, upside comes from any M&A/asset-sale signal or sharper-than-expected FY27 margin inflection.
• Fade the bounce if the stock rallies purely on 'undervalued' optics before FY27 evidence; use a stop if active-client growth and multi-product adoption do not accelerate within 1-2 quarters, because cheap can stay cheap through a prolonged transition.
• Monitor banking and incumbent cross-border payment beneficiaries for relative underperformance over the next 6-9 months; if OFX executes, the incremental share loss should show first in SME-facing bank fee pools and smaller fintech cohorts.